Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 748 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Immix Biopharma, Inc.
Market Cap
$527.94M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$523.60M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$532.96M
Operating Margin
-18477.83%
TTM Avg
-130078.39%
3Y Avg
-65039.20%
5Y Avg
-43359.46%
Market Cap
$519.25M
Operating Margin
-230460.98%
TTM Avg
-373160.49%
3Y Avg
-159952.53%
5Y Avg
-107112.87%
Market Cap
$518.16M
Operating Margin
-1407.52%
TTM Avg
-703.76%
3Y Avg
-114341.22%
5Y Avg
-77223.74%
Market Cap
$538.54M
Operating Margin
-1.90%
TTM Avg
-16.29%
3Y Avg
-781.66%
5Y Avg
-851.82%
Market Cap
$539.25M
Operating Margin
-91.36%
TTM Avg
-296.77%
3Y Avg
-6281.52%
5Y Avg
-4187.68%
Market Cap
$546.55M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$508.33M
Operating Margin
-46.01%
TTM Avg
-85.84%
3Y Avg
-83.08%
5Y Avg
-67.71%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | $527.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Monopar Therapeutics Inc. (MNPR)vs › | $523.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| ProKidney Corp. (PROK)vs › | $532.96M | -18477.83% | -130078.39% | -65039.20% | -43359.46% |
| Altimmune, Inc. (ALT)vs › | $519.25M | -230460.98% | -373160.49% | -159952.53% | -107112.87% |
| Crescent Biopharma, Inc. (CBIO)vs › | $518.16M | -1407.52% | -703.76% | -114341.22% | -77223.74% |
| Delcath Systems, Inc. (DCTH)vs › | $538.54M | -1.90% | -16.29% | -781.66% | -851.82% |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $539.25M | -91.36% | -296.77% | -6281.52% | -4187.68% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $546.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| 908 Devices Inc. (MASS)vs › | $508.33M | -46.01% | -85.84% | -83.08% | -67.71% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $548.18M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
